17 articles for JK von Frijtag Drabbe Künzel
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.

Leiden/Amsterdam Center For Drug Research
A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.

Leiden/Amsterdam Center For Drug Research
A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor.

Leiden/Amsterdam Center For Drug Research
Inhibition of nucleoside transport proteins by C8-alkylamine-substituted purines.

Leiden University
New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.

University of Leiden
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.

Leiden University
5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors.

Leiden University
5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor.

Leiden/Amsterdam Center For Drug Research
N6-cyclopentyl-3'-substituted-xylofuranosyladenosines: a new class of non-xanthine adenosine A1 receptor antagonists.

University of Ghent
Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor.

Leiden University
2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine A1, A2A and A3 receptor subtypes.

University of Amsterdam
Interference of linoleic acid fraction in some receptor binding assays.

Leiden University
2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.

Leiden/Amsterdam Center For Drug Research
2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.

Leiden/Amsterdam Center For Drug Research
2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.

Leiden/Amsterdam Center For Drug Research
Inhibition of nucleoside transport by new analogues of 4-nitrobenzylthioinosine: replacement of the ribose moiety by substituted benzyl groups.

Leiden University
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

National Institute of Diabetes